Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$373M |
| 2 |
Costco
COST
|
+$283M |
| 3 |
Bristol-Myers Squibb
BMY
|
+$270M |
| 4 |
Pfizer
PFE
|
+$240M |
| 5 |
Microsoft
MSFT
|
+$225M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$274M |
| 2 |
EMC CORPORATION
EMC
|
+$228M |
| 3 |
GAS
AGL Resources Inc
GAS
|
+$216M |
| 4 |
TECO ENERGY INC
TE
|
+$136M |
| 5 |
Charter Communications
CHTR
|
+$133M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.75% |
| 2 | Healthcare | 13.12% |
| 3 | Financials | 12.46% |
| 4 | Consumer Staples | 9.7% |
| 5 | Industrials | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ADAP
2101
DELISTED
Adaptimmune Therapeutics
ADAP
| $2.32M | ﹤0.01% |
328,700
+139,500
| +74% | +$1.06M |
2015 Q4
3 quarters
|
|
2102
Lifeway Foods
LWAY
$335M
| $2.32M | ﹤0.01% |
136,700
-3,300
| -2% | -$40.1K |
2013 Q2
13 quarters
|
|
|
FCB
2103
DELISTED
FCB Financial Holdings, Inc.
FCB
| $2.31M | ﹤0.01% |
+60,200
| New | +$2.22M |
2016 Q3
0 quarters
|
|
2104
Rigel Pharmaceuticals
RIGL
$917M
| $2.31M | ﹤0.01% |
62,980
-16,280
| -21% | -$467K |
2013 Q2
13 quarters
|
|
|
AVEO
2105
DELISTED
AVEO Pharmaceuticals, Inc.
AVEO
| $2.31M | ﹤0.01% |
259,540
+19,000
| +8% | +$179K |
2013 Q2
13 quarters
|
|
2106
National Bankshares
NKSH
$271M
| $2.31M | ﹤0.01% |
62,700
-500
| -0.8% | -$17.5K |
2013 Q2
13 quarters
|
|
2107
World Acceptance Corp
WRLD
$818M
| $2.31M | ﹤0.01% |
47,000
+34,500
| +276% | +$1.65M |
2016 Q2
1 quarter
|
|
2108
Idacorp
IDA
$7.83B
| $2.29M | ﹤0.01% |
29,300
-49,400
| -63% | -$3.9M |
2016 Q1
2 quarters
|
|
|
RTK
2109
DELISTED
Rentech, Inc.
RTK
| $2.29M | ﹤0.01% |
784,974
-6,536
| -0.8% | -$19.8K |
2014 Q4
7 quarters
|
|
2110
State Street Consumer Staples Select Sector SPDR ETF
XLP
$13.7B
| $2.28M | ﹤0.01% |
42,900
-65,400
| -60% | -$3.56M |
2014 Q4
7 quarters
|
|
|
ESND
2111
DELISTED
Essendant Inc.
ESND
| $2.28M | ﹤0.01% |
+110,922
| New | +$2.45M |
2016 Q3
0 quarters
|
|
|
NSTG
2112
DELISTED
NanoString Technologies, Inc.
NSTG
| $2.27M | ﹤0.01% |
+113,700
| New | +$1.8M |
2016 Q3
0 quarters
|
|
2113
Dover
DOV
$25.4B
| $2.27M | ﹤0.01% |
+38,130
| New | +$2.21M |
2016 Q3
0 quarters
|
|
|
AMNB
2114
DELISTED
American National Bankshares Inc
AMNB
| $2.27M | ﹤0.01% |
81,110
+6,010
| +8% | +$160K |
2013 Q3
12 quarters
|
|
2115
M/I Homes
MHO
$3.23B
| $2.26M | ﹤0.01% |
96,000
+76,100
| +382% | +$1.68M |
2015 Q4
3 quarters
|
|
|
STON
2116
DELISTED
StoneMor Inc.
STON
| $2.26M | ﹤0.01% |
90,188
-105,612
| -54% | -$2.66M |
2015 Q4
3 quarters
|
|
2117
Howard Hughes
HHH
$4.4B
| $2.26M | ﹤0.01% |
20,665
-22,029
| -52% | -$2.44M |
2015 Q3
4 quarters
|
|
2118
Plains GP Holdings
PAGP
$5.27B
| $2.25M | ﹤0.01% |
65,340
-342,170
| -84% | -$10.3M |
2015 Q4
3 quarters
|
|
2119
Acme United Corp
ACU
$238M
| $2.25M | ﹤0.01% |
107,600
+5,900
| +6% | +$122K |
2013 Q2
13 quarters
|
|
|
TESO
2120
DELISTED
Tesco Corp
TESO
| $2.24M | ﹤0.01% |
274,600
-91,100
| -25% | -$644K |
2014 Q1
10 quarters
|
|
2121
Agilysys
AGYS
$2.96B
| $2.24M | ﹤0.01% |
201,100
+16,100
| +9% | +$175K |
2013 Q2
13 quarters
|
|
2122
Diana Shipping
DSX
$351M
| $2.23M | ﹤0.01% |
1,220,067
+238,721
| +24% | +$438K |
2013 Q2
13 quarters
|
|
|
SFE
2123
DELISTED
Safeguard Scientifics, Inc.
SFE
| $2.23M | ﹤0.01% |
172,300
+36,100
| +27% | +$479K |
2015 Q2
5 quarters
|
|
2124
Camtek
CAMT
$7.13B
| $2.22M | ﹤0.01% |
739,000
+51,400
| +7% | +$132K |
2013 Q2
13 quarters
|
|
|
AVXS
2125
DELISTED
AveXis, Inc. Common Stock
AVXS
| $2.22M | ﹤0.01% |
53,900
+48,069
| +824% | +$1.83M |
2016 Q2
1 quarter
|
|
Similar funds
Renaissance Technologies's Q3 2016 Portfolio in Review
As of Q3 2016, Renaissance Technologies held 3,713 positions worth $56.6B, up 7.7% from $52.5B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Renaissance Technologies deployed $1.92B of net new capital in Q3 2016, opening 413 new positions and adding to 1,833 existing holdings. Its largest new stake was FedEx: 811,400 shares worth $142M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 15% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was CVS Health, an estimated $274M trimmed.
- Renaissance Technologies's largest Q3 2016 buy was FedEx: 811,400 shares worth $142M.
- Renaissance Technologies added most to Alphabet (Google) Class A in Q3 2016, an estimated $373M increase.
- Renaissance Technologies's biggest Q3 2016 reduction was CVS Health, cutting an estimated $274M.
- Renaissance Technologies fully exited EMC CORPORATION in Q3 2016, selling an estimated $228M.
- Renaissance Technologies's ten largest holdings make up 7.9% of its $56.6B portfolio in Q3 2016.
- Renaissance Technologies opened 413 new positions and closed 416 in Q3 2016.
- Renaissance Technologies's portfolio value rose 7.7% quarter-over-quarter to $56.6B.
Based on Renaissance Technologies's 13F filing for Q3 2016, filed 14 Nov 2016.